Lakeland Industries, Inc. (NASDAQ:LAKE) Given Average Recommendation of “Hold” by Analysts

Shares of Lakeland Industries, Inc. (NASDAQ:LAKE) have been assigned a consensus rating of “Hold” from the five ratings firms that are covering the stock, MarketBeat reports. Two investment analysts have rated the stock with a sell recommendation, one has issued a hold recommendation and two have assigned a buy recommendation to the company. The average 12 month target price among brokerages that have covered the stock in the last year is $16.50.

LAKE has been the subject of a number of analyst reports. Weiss Ratings restated a “sell (d)” rating on shares of Lakeland Industries in a research note on Wednesday, October 8th. Wall Street Zen downgraded shares of Lakeland Industries from a “hold” rating to a “strong sell” rating in a report on Saturday, December 13th. Zacks Research lowered shares of Lakeland Industries from a “hold” rating to a “strong sell” rating in a research report on Tuesday, December 16th. UBS Group set a $14.00 price target on Lakeland Industries in a research report on Wednesday, December 10th. Finally, Roth Capital dropped their price objective on Lakeland Industries from $27.00 to $19.00 and set a “buy” rating on the stock in a research note on Wednesday, December 10th.

Lakeland Industries Stock Performance

Shares of NASDAQ LAKE opened at $8.87 on Friday. The business’s 50-day simple moving average is $12.27 and its 200-day simple moving average is $13.97. The company has a debt-to-equity ratio of 0.28, a quick ratio of 1.48 and a current ratio of 3.83. Lakeland Industries has a 52 week low of $7.77 and a 52 week high of $27.28. The firm has a market cap of $86.98 million, a price-to-earnings ratio of -2.02 and a beta of 1.29.

Lakeland Industries (NASDAQ:LAKE) last announced its earnings results on Wednesday, September 21st. The medical instruments supplier reported $0.36 earnings per share (EPS) for the quarter. Lakeland Industries had a negative return on equity of 7.80% and a negative net margin of 19.41%.The firm had revenue of $27.47 million during the quarter. As a group, equities research analysts expect that Lakeland Industries will post 0.48 earnings per share for the current fiscal year.

Lakeland Industries Announces Dividend

The firm also recently declared a quarterly dividend, which was paid on Monday, November 24th. Stockholders of record on Monday, November 17th were issued a dividend of $0.03 per share. The ex-dividend date was Monday, November 17th. This represents a $0.12 dividend on an annualized basis and a dividend yield of 1.4%. Lakeland Industries’s payout ratio is -2.73%.

Insider Buying and Selling at Lakeland Industries

In other news, CFO Roger D. Shannon sold 8,869 shares of the firm’s stock in a transaction on Tuesday, December 16th. The shares were sold at an average price of $8.06, for a total value of $71,484.14. Following the sale, the chief financial officer owned 36,026 shares in the company, valued at approximately $290,369.56. This trade represents a 19.75% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is accessible through this hyperlink. Insiders purchased 4,727 shares of company stock valued at $40,608 over the last three months. 1.91% of the stock is currently owned by corporate insiders.

Institutional Trading of Lakeland Industries

Hedge funds have recently bought and sold shares of the stock. Kennedy Capital Management LLC bought a new position in shares of Lakeland Industries during the 3rd quarter worth about $2,287,000. Geode Capital Management LLC grew its position in Lakeland Industries by 115.9% during the second quarter. Geode Capital Management LLC now owns 217,786 shares of the medical instruments supplier’s stock worth $2,964,000 after buying an additional 116,901 shares in the last quarter. Royce & Associates LP increased its stake in Lakeland Industries by 10.0% during the third quarter. Royce & Associates LP now owns 1,178,670 shares of the medical instruments supplier’s stock valued at $17,444,000 after acquiring an additional 107,100 shares during the period. First Eagle Investment Management LLC raised its holdings in Lakeland Industries by 27.3% in the 2nd quarter. First Eagle Investment Management LLC now owns 278,756 shares of the medical instruments supplier’s stock valued at $3,794,000 after acquiring an additional 59,803 shares in the last quarter. Finally, UBS Group AG lifted its position in shares of Lakeland Industries by 818.1% in the 3rd quarter. UBS Group AG now owns 62,595 shares of the medical instruments supplier’s stock worth $926,000 after acquiring an additional 55,777 shares during the period. 71.69% of the stock is owned by institutional investors.

Lakeland Industries Company Profile

Lakeland Industries, Inc (NASDAQ:LAKE) is a global provider of high-performance protective apparel and accessories designed to safeguard workers in industrial, healthcare, laboratory, and emergency response environments. The company’s expertise lies in producing garments that shield against chemical, biological, radiological, and thermal risks, supporting safety protocols in sectors such as oil and gas, petrochemicals, pharmaceuticals, and first responders.

The product portfolio encompasses both single-use and reusable solutions, including chemical protective coveralls, flame-resistant garments, arc flash clothing, medical isolation gowns, and cleanroom suits.